News Focus
News Focus
icon url

stoxx

01/19/17 10:53 AM

#284000 RE: bigbro1 #283998

If one was to acquire a substantial amount of the float and make an offer for the remaining shares held by insiders, institutions and retailers at a very good premium what will the poison pill do?

Example
Roche bought Genentech 56% in 1990 for 2.1B then 44% in 2009 for 43.7Billion

How valuable is IP? How desperate is BP to fill their pipelines?

http://www.wipo.int/sme/en/documents/ip_pharma_fulltext.html

http://www.bioworld.com/content/big-pharma-continues-invest-immuno-oncology-innovation-0

Quote:
The space is hot and like many big pharmas, Merck is "scouring the world, looking for immunomodulatory agents," according to Eric Rubin, vice president and therapeutic area head of oncology early stage development at Merck Research Laboratories. (See BioWorld Today, July 29, 2015.)



icon url

JJ1223

01/19/17 11:25 AM

#284004 RE: bigbro1 #283998

Nothing? Much higher than normal